Online citations, reference lists, and bibliographies.
← Back to Search

Effect Of Chitosan On Epithelial Cell Tight Junctions

J. Smith, E. Wood, M. Dornish
Published 2004 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
AbstractPurpose. Chitosan has been proposed as a novel excipient for transepithelial drug-delivery systems. Chitosan is thought to disrupt intercellular tight junctions, thus increasing the permeability of an epithelium. The effect of chitosan on tight junction complex was investigated at the molecular level. Methods. Changes in barrier properties of Caco-2 cell monolayers, including transepithelial electrical resistance and permeability to horseradish peroxidase (HRP), were assessed in response to chitosan treatment. Changes in subcellular localization of the tight junction proteins zona occludens 1 (ZO-1) and occludin by immunofluorescence and Western blotting of cellular fractions were also assessed. Results. Chitosan was found to cause a dose-dependent reduction in transepithelial electrical resistance of Caco-2 monolayers of up to 83%. A corresponding increase in horseradish peroxidase permeability of up to 18 times greater than the control was also observed across the monolayer. Immunofluorescent localization of ZO-1 revealed loss of membrane-associated ZO-1 from discrete areas. Analysis of cellular fractions revealed a dose-dependent loss of ZO-1 and occludin from the cytosolic and membrane fractions into the cytoskeletal fraction. These changes did not occur because of chitosan-mediated ATP depletion.Conclusions. Chitosan-mediated tight junction disruption is caused by a translocation of tight junction proteins from the membrane to the cytoskeleton.
This paper references
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
10.1074/jbc.272.26.16133
Tight Junction Proteins Form Large Complexes and Associate with the Cytoskeleton in an ATP Depletion Model for Reversible Junction Assembly*
T. Tsukamoto (1997)
10.2174/0929867003374840
Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
N. Kanikkannan (2000)
Effects of chitosanglutamate and carbomer on epithelial tight junctions in vitro
G. Borchard (1996)
10.1016/S0016-5085(00)83843-3
Regulated expression of the myosin light chain kinase catalytic domain increases paracellular permeability and alters tight junction structure
J. Turner (2000)
10.1152/AJPGI.2000.279.3.G477
Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity.
M. Cereijido (2000)
10.1152/ajprenal.1998.274.1.F1
Molecular structure and assembly of the tight junction.
B. Denker (1998)
the effect of molecular weight and degree of deacetylation and exposure time
H. Holme (2000)
Effect of chitosan on Caco-2 on epithelial permeability and structure
V. Dodane (1999)
10.1152/ajprenal.1999.277.4.F524
A role for intracellular calcium in tight junction reassembly after ATP depletion-repletion.
J. Ye (1999)
10.1007/BF00146856
In vitro evaluation of biocompatibility of different wound dressing materials
P. C. Berscht (1995)
10.1016/0168-3659(95)00146-8
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
G. Borchard (1996)
10.1016/S0142-9612(98)00159-8
Biodegradation and distribution of water-soluble chitosan in mice.
Hayato Onishi (1999)
10.1016/s0306-3623(98)90009-x
Epithelial cell culture : a practical approach
A. J. Shaw (1996)
A role for intracellular calcium in tight junction reassembly after ATP depletionrepletion
J. Ye (1999)
10.1016/S0167-4889(01)00125-2
The effect of chitosan on stiffness and glycolytic activity of human bladder cells.
M. Lekka (2001)
10.1007/s004180000143
Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors
C. Klingler (2000)
The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line
G. Ranaldi (2002)
Modelling epithelial tissues in vitro
A. Shaw (1996)
10.1080/02648725.1999.10647970
Biomedical and pharmaceutical applications of alginate and chitosan.
O. Skaugrud (1999)
Assessment of cell polarity
Robert P. Hirt (1996)
Influence of chitosans on permeability of human intestinal epithelial ( Caco2 ) cell : the effect of molecular weight and degree of deacetylation and exposure time
A. Hagen H. Holme (2000)
10.1016/S0378-5173(99)00030-7
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
10.1053/GAST.2001.27060
Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia.
S. Walsh (2001)
Safety of Protasan: Ultrapure chitosan salts for biomedical and pharmaceutical use
M. Dornish (1997)
10.1016/S0928-0987(98)00016-5
Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.
A. Kotzé (1999)
10.1211/0022357011776441
Chitosan: some pharmaceutical and biological aspects ‐ an update
A. K. Singla (2001)



This paper is referenced by
10.1016/j.biomaterials.2017.10.022
Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
W. Fan (2018)
10.14334/JITV.V21I1.1343
Chitosan nanoparticle of hCG (Human Chorionic Gonadotrophin) hormone in increasing induction of dairy cattle ovulation
Fitra Aji Pamungkas (2016)
10.1089/JMF.2013.0131
New chitosan salt in gastro-resistant oral formulation could interfere with enteric bile salts emulsification of diet fats: preliminary laboratory observations and physiologic rationale.
FratterAndrea (2014)
10.1016/j.biomaterials.2009.09.101
The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents.
G. Sahay (2010)
Supercritical Fluid Aided Microencapsulation of Dry Powders
R. Carvallo (2011)
10.1016/j.ijpharm.2019.04.005
Dermal delivery of therapeutic DNAzymes via chitosan hydrogels
A. Eicher (2019)
10.1002/MASY.200900149
Application of Chitosan-Based Biomaterials for Blood Vessel Regeneration
Chao Deng (2010)
Design, preparation, and characterization of nanoparticles as delivery systems for bioactive phenolic phytochemicals
Zheng Li (2013)
10.1177/147323001003800215
Effect of Sperminated Pullulans on Drug Permeation through Isolated Rabbit Cornea and Determination of Ocular Irritation
N. Yu (2010)
1 Chitin and Chitosans : Characteristics , Eco-Friendly 2 Processes and Applications in Cosmetic Science 3
Cristina Casadidio (2019)
10.1016/j.ejmech.2008.10.007
Mucoadjuvant properties of lipo- and glycoconjugated derivatives of oligochitosans.
E. Svirshchevskaya (2009)
Biopharmaceutical approaches for improved drug delivery across ocular barriers
Ketan Hippalgaonkar (2011)
10.1016/j.ijpharm.2011.08.039
Effect of chitosan malate on viability and cytoskeletal structures morphology of Caco-2 cells.
C. Juliano (2011)
10.1016/J.EURPOLYMJ.2012.12.009
Chitosan-based biomaterials for tissue engineering
F. Croisier (2013)
10.1080/1061186X.2018.1512112
Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research
Sweet Naskar (2019)
Investigations on plant extracts for transdermal delivery of Repaglinide
Kaushal Neeraj (2010)
10.1016/j.colsurfb.2013.01.057
N-hydroxypropyltrimethylammonium polydimethylaminoethylmethacrylate sub-microparticles for oral delivery of insulin--an in vitro evaluation.
T. Sonia (2013)
10.2174/1381612825666190206211458
Advanced Approaches of Bioactive Peptide Molecules and Protein Drug Delivery Systems.
N. Thotakura (2018)
Loading and coating of microcontainers for oral drug delivery
C. Mazzoni (2019)
10.1080/10717540902896362
Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapy
M. Zhang (2009)
10.1016/j.jconrel.2008.01.019
Efficacy of pulmonary insulin delivery in diabetic rats: use of a model-based approach in the evaluation of insulin powder formulations.
M. Amidi (2008)
10.1039/c3fo60500k
Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells.
Z. Li (2014)
10.1016/j.ijpharm.2016.01.053
Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.
Binapani Mahaling (2016)
10.1186/2191-0855-3-37
Chitosan against cutaneous pathogens
J. Champer (2013)
10.1038/nrd1721
The rise and rise of drug delivery
Howard Rosen (2005)
10.3390/toxins10070276
Low Levels of Chito-Oligosaccharides Are Not Effective in Reducing Deoxynivalenol Toxicity in Swine Jejunal Explants
J. Gerez (2018)
10.2174/2212796810903020203
Functional Characterization of Chitin and Chitosan
I. Aranaz (2009)
10.1002/JBM.B.30372
Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
S. Sajeesh (2006)
10.22271/tpi.2020.v9.i3b.4448
Synthesis and evaluation of chitosan-alginate microspheres loaded with various combinations of enrofloxacin and selected phytochemicals against pathogenic bacteria
T. Manuroop (2020)
10.1039/C6RA06563E
Preparation of chitosan nanoparticles by nanoprecipitation and their ability as a drug nanocarrier
A. G. Luque-Alcaraz (2016)
10.1002/jps.21674
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.
S. R. K. Vaka (2009)
10.3390/pharmaceutics12030259
An Enteric-Coated Polyelectrolyte Nanocomplex Delivers Insulin in Rat Intestinal Instillations When Combined with a Permeation Enhancer
Svenja Sladek (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar